Montelukast Efficacy for Improvement of Adult Acute Phase Mild-Moderate Asthma Attack: A Clinical Trial Study
- 1 March 2021
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 16 (4) , 246-251
Abstract
Background: Asthma, an inflammatory disease of the respiratory tract, is one of the most frequent causes of referral to emergency departments. The aim of this study is to evaluate the efficacy of montelukast as a member of LTRAs for the improvement of pulmonary function and clinical symptoms of patients with asthma. Methods: The study was conducted on 80 patients with acute mild- moderate asthma, divided randomly into two groups of 40 subjects. A double-blind clinical trial was conducted on asthmatic patients who encounter an acute phase asthma attack. The experimental group received two montelukast 5 mg chewable tablets at arrival, accompanied by standard mild-moderate asthma treatment consisting of oxygen and nebulization with albuterol 2.5 mg and ipratropium bromide 0.5 mg in 3 doses for 60 minutes. The control group received standard mild-moderate asthma treatment plus placebo chewable tablets at the beginning without any leukotriene inhibitors. Pulmonary function tests, hemodynamic variables and Borg Dyspnea Scale were evaluated and analyzed at 0, 30, 60, 90 and 150 minutes in both case and control groups. Results: No significant differences were observed between the case and the control group in terms of PEFR and FEV1 measurements during the study at different time points [P > 0.05]. There were no significant differences in terms of hemodynamic variables [blood pressure, pulse and respiration rate, pressure of oxygen in arterial blood] and Borg Dyspnea Scale in both groups as well. Conclusion: The study findings showed that the montelukast administration in mild-moderate acute asthma attack setting had no significant impact on pulmonary function tests and clinical symptoms of the studied patients rather than standard asthma treatment.Keywords
This publication has 14 references indexed in Scilit:
- Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: Randomized, placebo controlled trialPulmonary Pharmacology & Therapeutics, 2015
- Montelukast versus Budesonide as a First Line Preventive Therapy in Mild Persistent Asthma in 2 to 18 yIndian Journal of Pediatrics, 2014
- Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly PatientsJournal of Asthma, 2012
- Prevalence of Asthma in Elementary School Age Children in Iran- A Systematic Review and Meta Analysis StudyPakistan Journal of Biological Sciences, 2011
- Asthma Epidemiology, Pathophysiology, and Initial EvaluationPediatrics in Review, 2009
- Best Treatment Guidelines For Bronchial AsthmaMedical Journal Armed Forces India, 2007
- Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthmaThorax, 2003
- A Randomized Controlled Trial of Intravenous Montelukast in Acute AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Montelukast Added to Inhaled Beclomethasone in Treatment of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999